Read More

Johns Hopkins Will Work With Clearmind On Alcohol Addiction Research Program

Israeli psychedelics biotech Clearmind Medicine (NASDAQ: CMND) has inked a research agreement with Johns Hopkins University School of Medicine (JHU) to conduct the first-in-human Phase I/IIa clinical trial on its proprietary MEAI-based compound CMND-100 for the potential treatment of Alcoho

CMND

Read More

Tingo Group Issues Response To Short-Seller’s Statement Of September 5, 2023; Co Noted That Hindenburg Has Again Attempted To Repeat Its Previous Allegations Despite The Completion Of A Detailed Investigation Into The Short-Seller Report Of June 6, 202…

Tingo Group, Inc. (NASDAQ:TIO) ("Tingo" or the "Company"), a profitable and fast growing fintech, agri-fintech and food company, today issues a response to a statement made by short seller Hindenburg

TIO